Video
Dr. Kishan calls for more prospective studies on the predictive nature of germline variants
Author(s):
“What really needs to be done to show that this works is to look prospectively,” says Amar U. Kishan, MD.
Video Player is loading.
In this video, Amar U. Kishan, MD, discusses the takeaways of the study, “Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation.” Kishan is an associate professor in the department of radiation oncology, chief of genitourinary oncology service, and vice chair of clinical and translational research at the University of California, Los Angeles.
Related Videos
Laura Davis, MD, on link between microplastics and bladder cancer
Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
Considerations for patient follow-up after onabotA administration
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Administering onabotA: Improving patient comfort and easing anxiety
Expert discusses genitourinary syndrome of menopause guidelines
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Joshua Heiman, MD, on phentermine plus topiramate for uric acid stone prevention
Amy Krambeck, MD, on innovation and building strong programs in endourology
Investigators evaluate patient outcomes with silicone vs polyurethane stents
Related Content
